Notice

New Mexico Register / Volume XXXI, Issue 5 / March 10, 2020

NOTICE OF REGULAR BOARD MEETING AND RULE HEARING

The New Mexico Board of Pharmacy will convene on April 16^th & 17^th, 2020 at 9:00 a.m. and continue until finished in the Board of Pharmacy Conference Room located at 5500 San Antonio Dr., NE, Albuquerque, NM 87109 for the purpose of conducting a regular board meeting.

The agenda is posted 72 hours prior to the scheduled meeting. You may view and download a copy of the agenda through the board’s website: www.rld.state.nm.us/boards/pharmacy.aspx. All proposed language regarding rule hearings is linked to the Agenda, the Notice to the Public on our website and the New Mexico Sunshine Portal.

Individuals petitioning the board regarding requests/waivers and/or interested persons wishing to comment on proposed language regarding rule hearings must submit documentation for presentation; via fax (505) 222-9845, mail or email to the Executive Director, Cheranne McCracken, Cheranne.McCracken@state.nm.us at least one week in advance of the scheduled meeting, if in attendance must also provide 12 copies of that documentation for distribution to board members and staff, as public comment is allowed during the rule hearing. (Board staff is not required to make copies.)

The board may go into Executive Session to discuss items pursuant to Section 10-15-1H(1), Section 10-15-1H(2), Section 10-15-1H(3) or Section 10-15-1H(7) of the Open Meeting Act. Agenda items may be executed at any time during the meeting to accommodate hearings.

If you are an individual with a disability who is in need of a reader, amplifier, qualified sign language interpreter, or any other form of auxiliary aid or service to attend or participate in the hearing or meeting, please contact Cheranne McCracken 505-222-9830 at least one week prior to the meeting or as soon as possible. Public documents, including the agenda and minutes, can be provided in various accessible formats. Please contact Cheranne McCracken, at 505-222-9830 or e-mail cheranne.mccracken@state.nm.us if a summary or other type of accessible format is needed.

The Board will address:

All Board Matters:

Rule Hearings:

April 16, 2020 9:10 a.m.

16.19.6 NMAC – PHARMACIES: Sections 1, 2, 17, and 21 - administrative updates and corrections. Amendment to Section 23, to allow the transfer of an original unfilled non-controlled substance prescription. Record keeping requirements are specified, and transfer or forwarding of controlled substance prescriptions is clarified for consistency with federal law.

STATUTORY AUTHORITY: Paragraph (6) of Subsection (A) of Section 61-11-6 NMSA 1978

16.19.30 NMAC – COMPOUNDING OF NON-STERILE PHARMACEUTICALS: Amendment to Sections 1, 2, and 3 – administrative updates. Amendment to Section 9, to allow a licensed pharmacy to compound non-sterile, non-controlled substance preparations for veterinarian office use. The office use preparation may be dispensed by a veterinarian for a patient under specific conditions, which include: the patient has an emergency condition that the compounded drug is necessary to treat, and timely access to a compounding pharmacy is not available. Up to a five day supply may be dispensed for use in a single course of treatment. Product from an outsourcing facility may not be dispensed.

STATUTORY AUTHORITY: Paragraph (6) of Subsection (A) of Section 61-11-6 NMSA 1978

Disciplinary Hearings: note – the information below is tentative. Final hearing date and time for each case will be included in the agenda posted to the board’s website at least 72 hours before the meeting. Additional hearing, if scheduled, will be included in the agenda.